Antiphospholipid syndrome: the need for new international classification criteria

References

• Edwards CJ, Hughes GR. Hughes syndrome (the antiphospholipid syndrome): 25 years old. Mod Rheumatol. 2008;18(2):119–124. PubMed PMID: 18317878
   PubMed Web of Science ®Google Scholar
• Hughes GR. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br Med J (Clin Res Ed). 1983 Oct 15;287(6399):1088–1089. . PubMed PMID: 6414579; PubMed Central PMCID: PMCPMC1549319.
   PubMedGoogle Scholar
• Harris EN, Gharavi AE, Patel SP, et al. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol. 1987 Apr;68(1):215–222. . PubMed PMID: 3652514; PubMed Central PMCID: PMCPMC1542695
   PubMed Web of Science ®Google Scholar
• Erkan D, Pierangeli SS. Antiphospholipid syndrome: insights and highlights from the 13th international congress on antiphospholipid antibodies. Springer Sci Bus Media. 2012.
   Google Scholar
• De Jesus GR, Benson AE, Chighizola CB, et al. 16th international congress on antiphospholipid antibodies task force report on obstetric antiphospholipid syndrome. Lupus. 2020 Oct;29(12):1601–1615. PubMed PMID: 32883160
   PubMedGoogle Scholar
• Asherson RA, Mackworth-Young CG, Harris EN, et al. Multiple venous and arterial thromboses associated with the lupus anticoagulant and antibodies to cardiolipin in the absence of SLE. Rheumatol Int. 1985;5(2):91–93. PubMed PMID: 3920748
   PubMed Web of Science ®Google Scholar
• Harris EN. SYNDROME OF THE BLACK SWAN. %J Rheumatology Rheumatology. 1987;265:324–326.
   Web of Science ®Google Scholar
• Harris EN. Clinical and serological features of the ‘antiphospholipid syndrome’. Brit J Rheumatol. 1987;26:19.
   Google Scholar
• Harris EJBJR. Clinical and serological features of the’antiphospholipid syndrome’. British Journal of Rheumatology. 1987;26:19.
   Google Scholar
• Nigel Harris E. History of the antiphospholipid syndrome %j revista Colombiana de Reumatología. 2009;16(4):326–329.
   Google Scholar
• Harris EN. A reassessment of the antiphospholipid syndrome. J Rheumatol. 1990 Jun;17(6):733–735. PubMed PMID: 2117657; eng
   PubMed Web of Science ®Google Scholar
• Piette JC. diagnostic and classification criteria for the antiphospholipid/cofactors syndrome: a “mission impossible’? Lupus. 1996 Oct;5(5):354–363. 1996 PubMed PMID: 8902760
   PubMed Web of Science ®Google Scholar
• Alarcón-Segovia D, Pérez-Vázquez ME, Villa AR, et al. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Semin Arthritis Rheum. 1992 Apr;21(5):275–286. PubMed PMID: 1604324; eng.
   PubMed Web of Science ®Google Scholar
• Piette JC, Wechsler B, Blétry O, et al. Quels critères pour le diagnostic du syndrome des antiphospholipides? La Revue de Médecine Interne. 1993 1993/01/01/. ;14(8):799–803.
   PubMedGoogle Scholar
• Galli M, Comfurius P, Maassen C, et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet. 1990 Jun 30;335(8705):1544–1547. PubMed PMID: 1972485; eng.
   PubMed Web of Science ®Google Scholar
• Matsuura E, Igarashi Y, Fujimoto M, et al. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet. 1990 Jul 21;336(8708):177–178. PubMed PMID: 1973491; eng
   PubMed Web of Science ®Google Scholar
• McNeil HP, Simpson RJ, Chesterman CN, et al. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A. 1990 Jun;87(11):4120–4124. PubMed PMID: 2349221; PubMed Central PMCID: PMCPMC54059. eng.
   PubMed Web of Science ®Google Scholar
• Asherson RA, Cervera R, Piette J-C, et al. The antiphospholipid syndrome: history, definition, classification, and differential diagnosis. Med. 1996;1:3–12.
   Google Scholar
• Laroche P, Berard M, Rouquette A-M, et al. Advantage of using both anionic and zwitterionic phospholipid antigens for the detection of antiphospholipid antibodies. Am J Clin Pathol. 1996;106(4):549–554. %J American Journal of Clinical Pathology.
   PubMed Web of Science ®Google Scholar
• Branch DW, Silver RM. Criteria for antiphospholipid syndrome: early pregnancy loss, fetal loss, or recurrent pregnancy loss? 1996/10/01 Lupus. 1996;55:409–413.
   PubMed Web of Science ®Google Scholar
• Piette JC. Towards improved criteria for the antiphospholipid syndrome. Lupus. 1998;7(Suppl 2):S149–57. PubMed PMID: 9814694.
   PubMedGoogle Scholar
• Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 1999 Jul;42(7):1309–1311. PubMed PMID: 10403256.
   PubMed Web of Science ®Google Scholar
• Harris EN, Pierangeli SS, Gharavi AE. Diagnosis of the antiphospholipid syndrome: a proposal for use of laboratory tests. Lupus. 1998;7(Suppl 2):S144–8. PubMed PMID: 9814693
   PubMedGoogle Scholar
• Brandt JT, Triplett DA, Alving B, et al. Criteria for the diagnosis of lupus anticoagulants: an update. on behalf of the subcommittee on lupus anticoagulant/antiphospholipid antibody of the scientific and standardisation committee of the ISTH. Thromb Haemost. 1995 Oct;74(4):1185–1190. PubMed PMID: 8560433
   PubMed Web of Science ®Google Scholar
• Pengo V, Tripodi A, Reber G, et al. Update of the guidelines for lupus anticoagulant detection. subcommittee on lupus anticoagulant/antiphospholipid antibody of the scientific and standardisation committee of the international society on thrombosis and haemostasis. J Thromb Haemost. 2009 Oct;7(10):1737–1740. PubMed PMID: 19624461
   PubMed Web of Science ®Google Scholar
• Cohen H, Mackie IJ, Devreese KMJ, et al. Clinical and laboratory practice for lupus anticoagulant testing: an international society of thrombosis and haemostasis scientific and standardization committee survey. J Thromb Haemost. 2019 Oct;17(10):1715–1732. PubMed PMID: 31271706
   PubMed Web of Science ®Google Scholar
• Bobba RS, Johnson SR, Davis AM. A review of the Sapporo and revised Sapporo criteria for the classification of antiphospholipid syndrome. Where do the revised Sapporo criteria add value? J Rheumatol. 2007 Jul;34(7):1522–1527. PubMed PMID: 17552042; eng
   PubMed Web of Science ®Google Scholar
• Westphal J, Kumar S, Rush J, et al. Addressing issues of face validity in the application of a clinical guideline. Eval Rev. 1997 Jun;21(3):379–387. PubMed PMID: 10183291
   PubMed Web of Science ®Google Scholar
• Lee RM, Brown MA, Branch DW, et al. Anticardiolipin and anti-beta2-glycoprotein-I antibodies in preeclampsia. Obstet Gynecol. 2003 Aug;102(2):294–300. PubMed PMID: 12907102
   PubMed Web of Science ®Google Scholar
• Branch DW, Porter TF, Rittenhouse L, et al. Antiphospholipid antibodies in women at risk for preeclampsia. Am J Obstet Gynecol. 2001 Apr;1845:825–832. PubMed PMID: 11303189; eng discussion 832–4
   PubMed Web of Science ®Google Scholar
• Triplett DA. Antiphospholipid antibodies. Arch Pathol Lab Med. 2002 Nov;126(11):1424–1429. . PubMed PMID: 12421152.
   PubMed Web of Science ®Google Scholar
• Lockshin MD, Sammaritano LR, Schwartzman S. Validation of the Sapporo criteria for antiphospholipid syndrome. Arthritis Rheum. 2000 Feb;43(2):440–443. . PubMed PMID: 10693886
   PubMedGoogle Scholar
• Weber M, Hayem G, Meyer O. The Sapporo criteria for antiphospholipid syndrome: comment on the article by Lockshin et al. Arthritis and Rheumatism. 2001;44(8):1965–1966.
   PubMedGoogle Scholar
• Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006 Feb;4(2):295–306. PubMed PMID: 16420554.
   PubMed Web of Science ®Google Scholar
• Obstetrics ACoOPJ, Gynecology. Practice bulletin# 33: diagnosis and management of preeclampsia and eclampsia. Obstetrics and Gynecology. 2002; 99(1): 159–167.
   Google Scholar
• Wong RC, Gillis D, Adelstein S, et al. Consensus guidelines on anti-cardiolipin antibody testing and reporting. Pathology. 2004 Feb;36(1):63–68. PubMed PMID: 14757559
   PubMed Web of Science ®Google Scholar
• Reber G, Tincani A, Sanmarco M, et al. Proposals for the measurement of anti-beta2-glycoprotein I antibodies. standardization group of the European forum on antiphospholipid antibodies. J Thromb Haemost. 2004 Oct;2(10):1860–1862. PubMed PMID: 15456509
   PubMed Web of Science ®Google Scholar
• Solano C, Lamuno M, Vargas A, et al. Comparison of the 1999 Sapporo and 2006 revised criteria for the classification of the antiphospholipid syndrome. Clin Exp Rheumatol. 2009 Nov-Dec;27(6):914–919. PubMed PMID: 20149305
   PubMed Web of Science ®Google Scholar
• Pengo V, Ruffatti A, Del Ross T, et al. Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile. J Thromb Haemost. 2013 Aug;11(8):1527–1531. PubMed PMID: 23601766
   PubMed Web of Science ®Google Scholar
• Park SH, Jang S, Park C-J, et al. Clinical application of revised laboratory classification criteria for antiphospholipid antibody syndrome: is the follow-up interval of 12 weeks instead of 6 weeks significantly useful? Biomed Res Int. 2016;2016:2641526. PubMed PMID: 27610369; eng
   PubMed Web of Science ®Google Scholar
• Forastiero R. Multiple antiphospholipid antibodies positivity and antiphospholipid syndrome criteria re-evaluation. Lupus. 2014 Oct;23(12):1252–1254. . PubMed PMID: 25228718
   PubMed Web of Science ®Google Scholar
• Singh JA, Solomon DH, Dougados M, et al. Development of classification and response criteria for rheumatic diseases. Arthritis Rheum. 2006 Jun 15;55(3):348–352. PubMed PMID: 16739201
   PubMed Web of Science ®Google Scholar
• Petri MA. Classification criteria for antiphospholipid syndrome: the case for cardiac valvular disease. J Rheumatol. 2004 Dec;31(12):2329–2330. PubMed PMID: 15570630
   PubMed Web of Science ®Google Scholar
• Lev S, Shoenfeld Y. Cardiac valvulopathy in the antiphospholipid syndrome. Clin Rev Allergy Immunol. 2002 Dec;23(3):341–348. . PubMed PMID: 12402416.
   PubMed Web of Science ®Google Scholar
• Zuily S, Huttin O, Mohamed S, et al. Valvular heart disease in antiphospholipid syndrome. Curr Rheumatol Rep. 2013 Apr;15(4):320. PubMed PMID: 23456852
   PubMed Web of Science ®Google Scholar
• Fleetwood T, Cantello R, Comi C. Antiphospholipid syndrome and the neurologist: from pathogenesis to therapy. Front Neurol. 2018;9:1001. PubMed PMID: 30534110; PubMed Central PMCID: PMCPMC6275383.
   PubMed Web of Science ®Google Scholar
• Fetoni V, Grisoli M, Salmaggi A, et al. Clinical and neuroradiological aspects of Sneddon’s syndrome and primary antiphospholipid antibody syndrome. A follow-up study. Neurol Sci. 2000 Jun;21(3):157–164. PubMed PMID: 11076004
   PubMed Web of Science ®Google Scholar
• Cervera R, Boffa MC, Khamashta MA, et al. The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe. Lupus. 2009 Sep;18(10):889–893. PubMed PMID: 19671788
   PubMed Web of Science ®Google Scholar
• Gasull T, DeGregorio-Rocasolano N, Zapata A, et al. Choline release and inhibition of phosphatidylcholine synthesis precede excitotoxic neuronal death but not neurotoxicity induced by serum deprivation. J Biol Chem. 2000 Jun 16;275(24):18350–18357. PubMed PMID: 10748226; eng
   PubMed Web of Science ®Google Scholar
• Kowal C, Degiorgio LA, Lee JY, et al. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19854–19859. PubMed PMID: 17170137; PubMed Central PMCID: PMCPMC1702320
   PubMed Web of Science ®Google Scholar
• Abreu MM, Danowski A, Wahl DG, et al. The relevance of “non-criteria” clinical manifestations of antiphospholipid syndrome: 14th international congress on antiphospholipid antibodies technical task force report on antiphospholipid syndrome clinical features. Autoimmun Rev. 2015 May;14(5):401–414. PubMed PMID: 25641203
   PubMed Web of Science ®Google Scholar
• Ames PRJ, Merashli M, Bucci T, et al. Antiphospholipid antibodies and autoimmune haemolytic anaemia: a systematic review and meta-analysis. Int J Mol Sci. 2020 Jun 9;21(11):4120. PubMed PMID: 32527000; PubMed Central PMCID: PMCPMC7313475
   Web of Science ®Google Scholar
• Nochy D, Daugas E, Droz D, et al. The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol. 1999 Mar;10(3):507–518. PubMed PMID: 10073601
   PubMed Web of Science ®Google Scholar
• Cervera R, Tektonidou MG, Espinosa G, et al. Task force on catastrophic Antiphospholipid Syndrome (APS) and non-criteria APS manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions. Lupus. 2011 Feb;20(2):165–173. PubMed PMID: 21303833
   PubMed Web of Science ®Google Scholar
• Teisseyre M, Perrochia H, Reboul P, et al. Primary antiphospholipid syndrome associated with anti-phospholipase A2 receptor antibody-positive membranous nephropathy. BMC Nephrol. 2020 May 24;21(1):196. PubMed PMID: 32448215; PubMed Central PMCID: PMCPMC7247250. eng
   PubMed Web of Science ®Google Scholar
• Hughes GR. The Prosser-White oration 1983. connective tissue disease and the skin. Clin Exp Dermatol. 1984 Nov;9(6):535–544. . PubMed PMID: 6437711
   PubMedGoogle Scholar
• Golden RL. Livedo reticularis in systemic lupus erythematosus. Arch Dermatol. 1963 Mar;87(3):299–301. PubMed PMID: 13948706
   PubMedGoogle Scholar
• Alarcon-Segovia D, Sanchez-Guerrero J. Primary antiphospholipid syndrome. J Rheumatol. 1989 Apr;16(4):482–488. PubMed PMID: 2746588
   PubMed Web of Science ®Google Scholar
• Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002 Apr;46(4):1019–1027. PubMed PMID: 11953980
   PubMed Web of Science ®Google Scholar
• Frances C, Niang S, Laffitte E, et al. Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases. Arthritis Rheum. 2005 Jun;52(6):1785–1793. PubMed PMID: 15934071
   PubMedGoogle Scholar
• Toubi E, Krause I, Fraser A, et al. Livedo reticularis is a marker for predicting multi-system thrombosis in antiphospholipid syndrome. Clin Exp Rheumatol. 2005 Jul-Aug;23(4):499–504. PubMed PMID: 16095119.
   PubMed Web of Science ®Google Scholar
• Udry S, Latino JO, Belizna C, et al. A high-risk laboratory profile of antiphospholipid antibodies and thrombosis is associated with a large number of extra-criteria manifestations in obstetric antiphospholipid syndrome. Immunol Res. 2019 Dec;67(6):478–485. PubMed PMID: 31873844.
   PubMed Web of Science ®Google Scholar
• Kontic M, Stojanovich L, Mijailovic-Ivkovic M, et al. Are the cutaneous manifestations in patients with primary antiphospholipid syndrome a marker for predicting lung manifestations? Clin Exp Rheumatol. 2018 Jan-Feb;36(1):56–61. PubMed PMID: 28770705
   PubMed Web of Science ®Google Scholar
• Pérez D, Stojanovich L, Naranjo L, et al. Presence of immune complexes of IgG/IgM bound to B2-glycoprotein I is associated with non-criteria clinical manifestations in patients with antiphospholipid syndrome. Front Immunol. 2018;9:2644. PubMed PMID: 30524428; eng
   PubMed Web of Science ®Google Scholar
• Radin M, Ugolini-Lopes MR, Sciascia S, et al. Extra-criteria manifestations of antiphospholipid syndrome: risk assessment and management. Semin Arthritis Rheum. 2018 Aug;48(1):117–120. PubMed PMID: 29395258
   PubMed Web of Science ®Google Scholar
• Uthman IW, Khamashta MA. Livedo racemosa: a striking dermatological sign for the antiphospholipid syndrome. J Rheumatol. 2006 Dec;33(12):2379–2382. PubMed PMID: 17143977
   PubMed Web of Science ®Google Scholar
• Wu S, Xu Z, Liang H. Sneddon’s syndrome: a comprehensive review of the literature. Orphanet J Rare Dis. 2014 Dec 31;9(1):215. . PubMed PMID: 25551694; PubMed Central PMCID: PMCPMC4302600.
   PubMedGoogle Scholar
• Kong SS, Azarfar A, Bhanusali N. Sneddon syndrome: under diagnosed disease, complex clinical manifestations and challenging diagnosis. A case-based review. Rheumatol Int. 2020 Jun 12. 10.1007/s00296-020-04625-1. PubMed PMID: 32533291.
   PubMed Web of Science ®Google Scholar
• Pregnolato F, Chighizola CB, Encabo S, et al. Anti-phosphatidylserine/prothrombin antibodies: an additional diagnostic marker for APS? Immunol Res. 2013 Jul;56(2–3):432–438. PubMed PMID: 23572433
   PubMed Web of Science ®Google Scholar
• Galli M, Beretta G, Daldossi M, et al. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies. Thromb Haemost. 1997 Mar;77(3):486–491. PubMed PMID: 9065999
   PubMed Web of Science ®Google Scholar
• Zohoury N, Bertolaccini ML, Rodriguez-Garcia JL, et al. Closing the serological gap in the antiphospholipid syndrome: the value of “non-criteria” antiphospholipid antibodies. J Rheumatol. 2017 Nov;44(11):1597–1602. PubMed PMID: 28864642
   PubMed Web of Science ®Google Scholar
• Mullen MT, Messe SR, Kasner SE, et al. Anti-phosphatidylserine-prothrombin antibodies are associated with outcome in a TIA cohort. Front Neurol. 2012;3:137. PubMed PMID: 23060855; PubMed Central PMCID: PMCPMC3460224
   PubMedGoogle Scholar
• Sciascia S, Sanna G, Murru V, et al. Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review. Thromb Haemost. 2014 Feb;111(2):354–364. PubMed PMID: 24172938
   PubMed Web of Science ®Google Scholar
• Fabris M, Giacomello R, Poz A, et al. The introduction of anti-phosphatidylserine/prothrombin autoantibodies in the laboratory diagnostic process of anti-phospholipid antibody syndrome: 6 months of observation. Auto Immun Highlights. 2014 Sep;5(2):63–67. PubMed PMID: 26000157; PubMed Central PMCID: PMCPMC4389041
   PubMedGoogle Scholar
• Radin M, Foddai SG, Cecchi I, et al. Antiphosphatidylserine/prothrombin antibodies: an update on their association with clinical manifestations of antiphospholipid syndrome. Thromb Haemost. 2020 Apr;120(4):592–598. PubMed PMID: 32185783; eng
   PubMed Web of Science ®Google Scholar
• Chayoua W, Yin DM, Kelchtermans H, et al. Is there an additional value in detecting anticardiolipin and anti-β2 glycoprotein I IgA antibodies in the antiphospholipid syndrome? Thromb Haemost. 2020 Jul 21;18(1):169–179. PubMed PMID: 32696448; eng
   Google Scholar
• Serrano M, Moran L, Martinez-Flores JA, et al. Immune complexes of beta-2-glycoprotein I and IgA antiphospholipid antibodies identify patients with elevated risk of thrombosis and early mortality after heart transplantation. Front Immunol. 2019;10:2891. PubMed PMID: 31921152; PubMed Central PMCID: PMCPMC6935976
   PubMed Web of Science ®Google Scholar
• Zhang S, Wu Z, Li J, et al. Evaluation of the clinical relevance of anti-annexin-A5 antibodies in Chinese patients with antiphospholipid syndrome. Clin Rheumatol. 2017 Feb;36(2):407–412. PubMed PMID: 28000012
   PubMed Web of Science ®Google Scholar
• Arachchillage DR, Efthymiou M, Mackie IJ, et al. Anti-protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndrome. J Thromb Haemost. 2014 Nov;12(11):1801–1809. PubMed PMID: 25196808
   PubMed Web of Science ®Google Scholar
• Sorice M, Griggi T, Circella A, et al. Protein S antibodies in acquired protein S deficiencies [letter]. Blood. 1994 Apr 15;83(8):2383–2384. PubMed PMID: 8161807.
   PubMed Web of Science ®Google Scholar
• Ortona E, Capozzi A, Colasanti T, et al. Vimentin/cardiolipin complex as a new antigenic target of the antiphospholipid syndrome. Blood. 2010 Oct 21;116(16):2960–2967. PubMed PMID: 20634382; eng
   PubMed Web of Science ®Google Scholar
• Sorice M, Ferro D, Misasi R, et al. Evidence for anticoagulant activity and beta2-GPI accumulation in late endosomes of endothelial cells induced by anti-LBPA antibodies. Thromb Haemost. 2002 Apr;87(4):735–741. PubMed PMID: 12008959.
   PubMed Web of Science ®Google Scholar
• Andreoli L, Chighizola CB, Nalli C, et al. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome. Arthritis Rheumatol (Hoboken). 2015 May;67(8):2196–2204. PubMed PMID: 25939498; eng
   PubMed Web of Science ®Google Scholar
• Radin M, Cecchi I, Roccatello D, et al. Prevalence and thrombotic risk assessment of anti-β2 glycoprotein i domain i antibodies: a systematic review. Semin Thromb Hemost. 2018 Jul;44(5):466–474. PubMed PMID: 28778105; eng
   PubMed Web of Science ®Google Scholar
• Devreese KM. Standardization of antiphospholipid antibody assays. Where do we stand? Lupus. 2012 Jun;21(7):718–721. . PubMed PMID: 22635211
   PubMed Web of Science ®Google Scholar
• Devreese KMJ, De Groot PG, De Laat B, et al. Guidance from the scientific and standardization committee for lupus anticoagulant/antiphospholipid antibodies of the international society on thrombosis and haemostasis: update of the guidelines for lupus anticoagulant detection and interpretation. J Thromb Haemost. 2020 Nov;18(11):2828–2839. PubMed PMID: 33462974
   PubMed Web of Science ®Google Scholar
• Sciascia S, Sanna G, Murru V, et al. GAPSS: the global anti-phospholipid syndrome score. Rheumatology (Oxford). 2013 Aug;52(8):1397–1403. PubMed PMID: 23315788
   PubMed Web of Science ®Google Scholar
• Radin M, Sciascia S, Erkan D, et al. The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: results from the APS ACTION cohort. Semin Arthritis Rheum. 2019 Dec;49(3):464–468. PubMed PMID: 31153708; PubMed Central PMCID: PMCPMC7402528
   PubMed Web of Science ®Google Scholar
• Otomo K, Atsumi T, Amengual O, et al. Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events. Arthritis Rheum. 2012 Feb;64(2):504–512. PubMed PMID: 21953404
   PubMedGoogle Scholar
• Barbhaiya M, Zuily S, Ahmadzadeh Y, et al. Development of new international antiphospholipid syndrome classification criteria phase I/II report: generation and reduction of candidate criteria. Arthritis Care Res (Hoboken). 2020 Nov 30; 10.1002/acr.24520 [ PubMed PMID: 33253499]
   Web of Science ®Google Scholar